Insulin resistance is not associated with liver fibrosis progression in HIV/hepatitis C virus-coinfected patients

Journal of Viral Hepatitis

Volumn 13, Issue 7, 2006, Pages 449-456

  Merchante, N ^a   Macias J ^a   Ramayo, E ^a   Vergara, S ^a   Garcia Garcia J A ^a   Mira, J A ^a   Corzo, J E ^a   Gomez Mateos J M ^a   Lozano, F ^a   Pineda, J A ^a  

^a HOSPITAL UNIVERSITARIO DE VALME   (Spain)

Author keywords

Antiretroviral therapy; Chronic hepatitis C; Insulin resistance; Liver fibrosis

Indexed keywords

INSULIN; NEVIRAPINE;

ADULT; ARTICLE; CHRONIC HEPATITIS; DIAGNOSTIC KIT; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS C; HIV; HIV INFECTIONS; HUMANS; INSULIN RESISTANCE; LIVER CIRRHOSIS; MALE;

EID: 33745206132     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2005.00708.x     Document Type: Article

References (30)

1. Carr A Samaras K Burton S et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 1998 12: 51 58.
2. Walli R Herford O Michl GM et al. Treatment with protease inhibitors is associated with peripheral insulin resistance and impaired glucose tolerance in HIV-1 infected patients. AIDS 1998 12: 167 173.
3. Mulligan K Grunfeld C Tai VW et al. Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection. J Acquir Immune Defic Syndr 2000 23: 35 43.
4. Delgado-Borrego A Casson D Schoenfeld D et al. Hepatitis C virus is independently associated with increased insulin resistance after liver transplantation. Transplantation 2004 77: 703 710.
5. Shintani Y Fujie H Miyoshi H et al. Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance. Gastroenterology 2004 126: 840 848.
6. Hui JM Sud A Farrel GC et al. Insulin resistance is associated with chronic hepatitis C and virus infection fibrosis progression. Gastroenterology 2003 125: 1695 1704.
7. Petit JM Bour JB Galland-Jos C et al. Risks factors for diabetes mellitus and early insulin resistance in chronic hepatitis C. J Hepatol 2001 35: 279 283.
8. Maeno T Okumura A Ishikawa A et al. Mechanisms of increased insulin resistance in non-cirrhotic patients with chronic hepatitis C virus infection. J Gastroenterol Hepatol 2003 18: 1358 1363.
9. Sud A Hui JM Farell GC et al. Improved prediction of fibrosis in chronic hepatitis C using measures of insulin resistance in a probability index. Hepatology 2004 39: 1239 1247.
10. Muzzi A Leandro G Rubia-Brandt L et al. Insulin resistance is associated with liver fibrosis in non-diabetic chronic hepatitis C patients. J Hepatol 2005 42: 41 46.
11. Macías J Castellano V Merchante N et al. Effect of antiretroviral drugs on liver fibrosis in HIV-infected patients with chronic hepatitis C: harmful impact of nevirapine. AIDS 2004 18: 767 774.
12. Martínez-Sierra C Arizcorreta A Díaz F et al. Progression of chronic hepatitis C to liver fibrosis and chirrosis in patients coinfected with hepatitis C virus and human immunodeficiency virus. Clin Infect Dis 2003 36: 491 498.
13. Benhamou Y Martino V Bochet M et al. Factors affecting liver fibrosis in human immunodeficiency virus- and hepatitis C virus-coinfected patients: impact of portease inhibitor therapy. Hepatology 2001 34: 283 287.
14. Mohsen AH Easterbrook PJ Taylor C et al. Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients. Gut 2003 52: 1035 1040.
15. Tural C Fuster D Tor J et al. Time on antiretroviral therapy is a protective factor for liver fibrosis in HIV and hepatitis C virus (HCV) co-infected patients. J Viral Hepat 2003 10: 118 125.
16. Poynard T Bedossa P Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997 349: 825 832.
17. Thomas DL Vlahov D Solomon L et al. Correlates of hepatitis C virus infections among injection drug users. Medicine (Baltimore) 1995, 74: 212 220.
18. Matthews DR Hosker JP Rudenski AS Naylor BA Treacher DF Tumer RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28: 412 419.
19. Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 1991 13: 372 374.
20. Ascaso JF Romero P Real JT Priego A Valdecabres C Carmena R. Quantification of insulin resistance with the values of basal insulin and HOMA index in a non-diabetic population. Med Clin (Barc) 2001 117: 530 533.
21. Ascaso JF Pardo S Real JT Lorente RI Priego A Carmena R. Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Diabetes Care 2003 26: 3320 3325.
22. Emoto M Nishizawa Y Maekawa K et al. Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas. Diabetes Care 1999 22: 818 822.
23. Bonora E Targher G Alberiche M et al. Homeostasis model asessement closely mirrors the glucose clamp technique in the assessment of insulin sensivity: stuidies in subjects with various degrees of glucose tolerance and insulin sensivity. Diabetes Care 2000 23: 57 63.
24. Poynard T Ratziu V Charlotte F Goodman Z McHutchinson J Albrecht J. Rates and risks of liver fibrosis progression in patients with chronic hepatitis C. J Hepatol 2001 34: 730 739.
25. Bonora E Kiechl S Willeit J et al. Population-based incidence rates and risks factors for type 2 diabetes in white individuals: the Bruneck study. Diabetes 2004 53: 1782 1789.
26. Castera L Hezode C Roudot-Thoraval F et al. Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies. Gut 2003 52: 288 292.
27. Adinolfi LE Gambardella M Andreana A Tripodi MF Utili R Ruggiero G. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 2001 33: 1358 1364.
28. Hourigan LF Macdonald GA Purdie D et al. Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis. Hepatology 1999 29: 1215 1219.
29. Sulkowski MS Mehta SH Torbenson M et al. Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C virus. AIDS 2005 19: 585 592.
30. Ghany MG Kleiner DE Alter H et al. Progression of fibrosis in chronic hepatitis C. Gastroenterology 2003 124: 97 104.